Akamis Bio Employee Directory
Biotechnology ResearchMassachusetts, United States11-50 Employees
Akamis Bio is a clinical-stage biotechnology company based in Cambridge, Massachusetts, focused on developing systemic immunotherapies for solid tumors. The company applies its Tumor-Specific Immuno-Gene Therapy platform to deliver immunotherapeutic proteins and related biomolecules directly to tumors. Its lead program, NG-350A, is designed to drive intratumoral expression of a CD40 agonist monoclonal antibody, with an initial focus on locally advanced rectal cancer. Operating in the biotechnology research sector, Akamis Bio seeks to advance cancer treatments by modulating the tumor immune environment. The company has pursued collaborations with cancer-immunotherapy research initiatives to support its development programs. In October 2025, it announced that NG-350A received FDA Fast Track designation for the treatment of mismatch repair-proficient locally advanced rectal cancer.
1-888-653-2347 
support@leadiq.com 
